RadNet, Inc. (RDNT) Stock Forecast
Data as of Jun 19, 2026Healthcare · Current price $53.01 (+0.36%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 3, 2026 | Brian Tanquilut | Jefferies | $91.00 | +71.7% |
| Dec 17, 2025 | David MacDonald | Truist Financial | $90.00 | +69.8% |
| Nov 14, 2025 | John Ransom | Raymond James | $95.00 | +79.2% |
| Jul 10, 2025 | David MacDonald | Truist Financial | $74.00 | +39.6% |
| Jan 22, 2025 | David MacDonald | Truist Financial | $88.00 | +66.0% |
| Dec 5, 2024 | Brian Tanquilut | Jefferies | $100.00 | +88.7% |
| Nov 29, 2024 | David MacDonald | Truist Financial | $94.00 | +77.3% |
| Sep 23, 2024 | David MacDonald | Truist Financial | $80.00 | +50.9% |
| Sep 19, 2024 | Brian Tanquilut | Jefferies | $80.00 | +50.9% |
| Sep 6, 2024 | Andrew Mok | Barclays | $79.00 | +49.0% |
| Aug 8, 2024 | Andrew Mok | Barclays | $57.00 | +7.5% |
| May 15, 2024 | David MacDonald | Truist Financial | $63.00 | +18.9% |
| Mar 28, 2024 | David MacDonald | Truist Financial | $55.00 | +3.8% |
| Jun 26, 2023 | Quinn Bolton | Needham | $37.00 | -30.2% |
Top Analysts Covering RDNT
RDNT vs Sector & Market
| Metric | RDNT | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.40 |
| Analyst Count | 2 | 8 | 18 |
| Target Upside | +51.6% | +11475.0% | +16.8% |
| P/E Ratio | -233.37 | 4.14 | 35.58 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $2.43B | $2.46B | $2.49B | 4 |
| 2027-03-31 | $621M | $631M | $645M | 1 |
| 2027-06-30 | $656M | $666M | $681M | 2 |
| 2027-09-30 | $692M | $703M | $719M | 2 |
| 2027-12-31 | $719M | $730M | $747M | 1 |
| 2028-03-31 | $690M | $701M | $718M | 1 |
| 2028-06-30 | $730M | $741M | $758M | 1 |
| 2028-09-30 | $771M | $783M | $801M | 1 |
| 2028-12-31 | $800M | $813M | $832M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $0.38 | $0.63 | $0.84 | 4 |
| 2027-03-31 | $-0.05 | $-0.05 | $-0.05 | 2 |
| 2027-06-30 | $0.26 | $0.27 | $0.28 | 1 |
| 2027-09-30 | $0.38 | $0.39 | $0.40 | 1 |
| 2027-12-31 | $0.43 | $0.43 | $0.45 | 2 |
| 2028-03-31 | $-0.01 | $-0.01 | $-0.01 | 3 |
| 2028-06-30 | $0.34 | $0.35 | $0.36 | 2 |
| 2028-09-30 | $0.38 | $0.39 | $0.40 | 2 |
| 2028-12-31 | $0.41 | $0.42 | $0.43 | 3 |
Frequently Asked Questions
What is the analyst consensus for RDNT?
The consensus among 2 analysts covering RadNet, Inc. (RDNT) is Buy with an average price target of $92.00.
What is the highest price target for RDNT?
The highest price target for RDNT is $100.00, set by Brian Tanquilut at Jefferies on 2024-12-05.
What is the lowest price target for RDNT?
The lowest price target for RDNT is $37.00, set by Quinn Bolton at Needham on 2023-06-26.
How many analysts cover RDNT?
2 analysts have issued ratings for RadNet, Inc. in the past 12 months.
Is RDNT a buy or sell right now?
Based on 2 analyst ratings, RDNT has a consensus rating of Buy (2.00/5) with a +51.6% upside to the consensus target of $92.00.
What are the earnings estimates for RDNT?
Analysts estimate RDNT will report EPS of $0.63 for the period ending 2026-12-31, with revenue estimated at $2.46B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.